{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:28:23Z","timestamp":1785540503690,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Myocardial infarction (MI) and subsequent heart failure are frequently accompanied by chronic kidney disease, further impairing outcomes and complicating treatment. To better understand heart-kidney crosstalk, we used RNA sequencing data to infer interorgan signalling after experimentally induced MI in mice, focusing on secreted biomolecules and interorgan cross talk that may drive cardiorenal syndrome (CRS). To assess acute and chronic effects, we examined kidneys at 5d and 28d post-MI, evaluating changes in renal gene expression and fibrosis. During the acute phase 5d post-MI, several genes inferred to target kidney receptors were highly upregulated in the cardiac infarct zone, with\n                    <jats:italic>Postn<\/jats:italic>\n                    and\n                    <jats:italic>Spp1<\/jats:italic>\n                    being the most probable ligands. However, only minor changes in gene expression were detected in the kidney 5d post-MI. At 28d post-MI, renal fibrosis and the number of differentially expressed genes (DEGs) in the kidney increased. Gene ontology enrichment suggested metabolic adaptions as part of a long-term response. Based on upregulated DEGs in kidney 28d post-MI, we suggest two kidney-to-heart interactions:\n                    <jats:italic>Slitrk6<\/jats:italic>\n                    -\n                    <jats:italic>Ptprs<\/jats:italic>\n                    and\n                    <jats:italic>Gdf15<\/jats:italic>\n                    -\n                    <jats:italic>Tgfbr2.<\/jats:italic>\n                    In vitro, GDF-15 treatment of human cardiac fibroblasts induced pro-fibrotic gene expression, mirroring in vivo changes in the heart. Our data suggest that MI in mice elicits minimal acute response in kidney but triggers chronic transcriptional and pro-fibrotic changes in kidney, potentially driven by altered renal metabolism. The inference of interorgan signalling molecules such as GDF-15 points towards candidate mediators of CRS and provides a basis for future mechanistic and clinical studies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-30712-z","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T20:15:10Z","timestamp":1764965710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systems biology approach uncovers candidates for kidney-heart interorgan crosstalk after myocardial infarction"],"prefix":"10.1038","volume":"15","author":[{"given":"Hanna","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Kupsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia K.","family":"Haacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Bacmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Hilgendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Dechend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"30712_CR1","doi-asserted-by":"publisher","first-page":"F974","DOI":"10.1152\/ajprenal.00624.2017","volume":"316","author":"S Liu","year":"2019","unstructured":"Liu, S. Heart-kidney interactions: Mechanistic insights from animal models. Am J Physiol Renal Physiol 316, F974\u2013F985. https:\/\/doi.org\/10.1152\/ajprenal.00624.2017 (2019).","journal-title":"Am J Physiol Renal Physiol"},{"key":"30712_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.amjcard.2007.02.047","volume":"100","author":"WB Eijkelkamp","year":"2007","unstructured":"Eijkelkamp, W. B. et al. Effect of first myocardial ischemic event on renal function. Am J Cardiol 100, 7\u201312. https:\/\/doi.org\/10.1016\/j.amjcard.2007.02.047 (2007).","journal-title":"Am J Cardiol"},{"key":"30712_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ekir.2018.03.005","volume":"3","author":"K Esmeijer","year":"2018","unstructured":"Esmeijer, K. et al. Cardiovascular risk factors accelerate kidney function decline in post-myocardial infarction patients: The alpha omega cohort study. Kidney Int Rep 3, 879\u2013888. https:\/\/doi.org\/10.1016\/j.ekir.2018.03.005 (2018).","journal-title":"Kidney Int Rep"},{"key":"30712_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nm.4326","volume":"23","author":"K Fujiu","year":"2017","unstructured":"Fujiu, K. et al. A heart-brain-kidney network controls adaptation to cardiac stress through tissue macrophage activation. Nat Med 23, 611\u2013622. https:\/\/doi.org\/10.1038\/nm.4326 (2017).","journal-title":"Nat Med"},{"key":"30712_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","volume":"28","author":"AJ de Bold","year":"1981","unstructured":"de Bold, A. J., Borenstein, H. B., Veress, A. T. & Sonnenberg, H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28, 89\u201394. https:\/\/doi.org\/10.1016\/0024-3205(81)90370-2 (1981).","journal-title":"Life Sci"},{"key":"30712_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003101","author":"CM Dewey","year":"2016","unstructured":"Dewey, C. M., Spitler, K. M., Ponce, J. M., Hall, D. D. & Grueter, C. E. Cardiac-secreted factors as peripheral metabolic regulators and potential disease biomarkers. J Am Heart Assoc https:\/\/doi.org\/10.1161\/JAHA.115.003101 (2016).","journal-title":"J Am Heart Assoc"},{"key":"30712_CR7","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","volume":"60","author":"C Ronco","year":"2012","unstructured":"Ronco, C., Cicoira, M. & McCullough, P. A. Cardiorenal syndrome type 1: Pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 60, 1031\u20131042. https:\/\/doi.org\/10.1016\/j.jacc.2012.01.077 (2012).","journal-title":"J Am Coll Cardiol"},{"key":"30712_CR8","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski, J., Floege, J., Fliser, D., Bohm, M. & Marx, N. Cardiovascular disease in chronic kidney disease: Pathophysiological insights and therapeutic options. Circulation 143, 1157\u20131172. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686 (2021).","journal-title":"Circulation"},{"key":"30712_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","volume":"380","author":"M Tonelli","year":"2012","unstructured":"Tonelli, M. et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study. Lancet 380, 807\u2013814. https:\/\/doi.org\/10.1016\/S0140-6736(12)60572-8 (2012).","journal-title":"Lancet"},{"key":"30712_CR10","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1111\/chf.12030","volume":"19","author":"E Alhaj","year":"2013","unstructured":"Alhaj, E. et al. Uremic cardiomyopathy: An underdiagnosed disease. Congest Heart Fail 19, E40-45. https:\/\/doi.org\/10.1111\/chf.12030 (2013).","journal-title":"Congest Heart Fail"},{"issue":"Suppl 1","key":"30712_CR11","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.2215\/CJN.04860709","volume":"4","author":"RJ Glassock","year":"2009","unstructured":"Glassock, R. J., Pecoits-Filho, R. & Barberato, S. H. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4(Suppl 1), S79-91. https:\/\/doi.org\/10.2215\/CJN.04860709 (2009).","journal-title":"Clin J Am Soc Nephrol"},{"key":"30712_CR12","doi-asserted-by":"publisher","first-page":"E8727","DOI":"10.1073\/pnas.1721635115","volume":"115","author":"S Hinrichs","year":"2018","unstructured":"Hinrichs, S. et al. Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction. Proc Natl Acad Sci USA 115, E8727\u2013E8736. https:\/\/doi.org\/10.1073\/pnas.1721635115 (2018).","journal-title":"Proc Natl Acad Sci USA"},{"key":"30712_CR13","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.107.714147","volume":"117","author":"D Westermann","year":"2008","unstructured":"Westermann, D. et al. Biglycan is required for adaptive remodeling after myocardial infarction. Circulation 117, 1269\u20131276. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.714147 (2008).","journal-title":"Circulation"},{"key":"30712_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00395-014-0428-7","volume":"109","author":"D Lindner","year":"2014","unstructured":"Lindner, D. et al. Cardiac fibroblasts support cardiac inflammation in heart failure. Basic Res Cardiol 109, 428. https:\/\/doi.org\/10.1007\/s00395-014-0428-7 (2014).","journal-title":"Basic Res Cardiol"},{"key":"30712_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","volume":"4","author":"D Westermann","year":"2011","unstructured":"Westermann, D. et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4, 44\u201352. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.931451 (2011).","journal-title":"Circ Heart Fail"},{"key":"30712_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/875742","volume":"2012","author":"D Lindner","year":"2012","unstructured":"Lindner, D. et al. Differential expression of matrix metalloproteases in human fibroblasts with different origins. Biochem. Res. Int. 2012, 875742. https:\/\/doi.org\/10.1155\/2012\/875742 (2012).","journal-title":"Biochem. Res. Int."},{"key":"30712_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"30712_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4161\/epi.26931","volume":"9","author":"AM Zawada","year":"2014","unstructured":"Zawada, A. M. et al. Massive analysis of cDNA ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease. Epigenetics 9, 161\u2013172. https:\/\/doi.org\/10.4161\/epi.26931 (2014).","journal-title":"Epigenetics"},{"key":"30712_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol"},{"key":"30712_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021800","volume":"6","author":"F Supek","year":"2011","unstructured":"Supek, F., Bosnjak, M., Skunca, N. & Smuc, T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE 6, e21800. https:\/\/doi.org\/10.1371\/journal.pone.0021800 (2011).","journal-title":"PLoS ONE"},{"key":"30712_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.aat5031","volume":"365","author":"BJ Stewart","year":"2019","unstructured":"Stewart, B. J. et al. Spatiotemporal immune zonation of the human kidney. Science 365, 1461\u20131466. https:\/\/doi.org\/10.1126\/science.aat5031 (2019).","journal-title":"Science"},{"key":"30712_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","volume":"608","author":"C Kuppe","year":"2022","unstructured":"Kuppe, C. et al. Spatial multi-omic map of human myocardial infarction. Nature 608, 766\u2013777. https:\/\/doi.org\/10.1038\/s41586-022-05060-x (2022).","journal-title":"Nature"},{"key":"30712_CR23","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s00018-011-0778-3","volume":"68","author":"LF Lau","year":"2011","unstructured":"Lau, L. F. CCN1\/CYR61: The very model of a modern matricellular protein. Cell Mol Life Sci 68, 3149\u20133163. https:\/\/doi.org\/10.1007\/s00018-011-0778-3 (2011).","journal-title":"Cell Mol Life Sci"},{"key":"30712_CR24","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/sj.emboj.7601596","volume":"26","author":"CC Chen","year":"2007","unstructured":"Chen, C. C. et al. Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling. EMBO J 26, 1257\u20131267. https:\/\/doi.org\/10.1038\/sj.emboj.7601596 (2007).","journal-title":"EMBO J"},{"key":"30712_CR25","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1158\/1541-7786.MCR-07-2086","volume":"6","author":"R Meyuhas","year":"2008","unstructured":"Meyuhas, R. et al. A Key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in tumor cells. Mol Cancer Res 6, 1397\u20131409. https:\/\/doi.org\/10.1158\/1541-7786.MCR-07-2086 (2008).","journal-title":"Mol Cancer Res"},{"key":"30712_CR26","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1210\/en.2009-1195","volume":"151","author":"N Wolf","year":"2010","unstructured":"Wolf, N. et al. Regulation of the matricellular proteins CYR61 (CCN1) and NOV (CCN3) by hypoxia-inducible factor-1alpha and transforming-growth factor-beta3 in the human trophoblast. Endocrinology 151, 2835\u20132845. https:\/\/doi.org\/10.1210\/en.2009-1195 (2010).","journal-title":"Endocrinology"},{"key":"30712_CR27","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1046\/j.1523-1755.2002.00633.x","volume":"62","author":"Y Muramatsu","year":"2002","unstructured":"Muramatsu, Y. et al. Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int 62, 1601\u20131610. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00633.x (2002).","journal-title":"Kidney Int"},{"key":"30712_CR28","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.118.035047","volume":"138","author":"K Shirakawa","year":"2018","unstructured":"Shirakawa, K. et al. IL (Interleukin)-10-STAT3-Galectin-3 axis is essential for osteopontin-producing reparative macrophage polarization after myocardial infarction. Circulation 138, 2021\u20132035. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035047 (2018).","journal-title":"Circulation"},{"key":"30712_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071047","author":"K Shirakawa","year":"2021","unstructured":"Shirakawa, K. & Sano, M. Osteopontin in cardiovascular diseases. Biomolecules https:\/\/doi.org\/10.3390\/biom11071047 (2021).","journal-title":"Biomolecules"},{"key":"30712_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jjcc.2013.09.013","volume":"63","author":"S Zhao","year":"2014","unstructured":"Zhao, S. et al. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J Cardiol 63, 373\u2013378. https:\/\/doi.org\/10.1016\/j.jjcc.2013.09.013 (2014).","journal-title":"J Cardiol"},{"key":"30712_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1046\/j.1523-1755.1999.00580.x","volume":"56","author":"V Ophascharoensuk","year":"1999","unstructured":"Ophascharoensuk, V. et al. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56, 571\u2013580. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00580.x (1999).","journal-title":"Kidney Int"},{"key":"30712_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2362.2010.02271.x","volume":"40","author":"J Lorenzen","year":"2010","unstructured":"Lorenzen, J. et al. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. Eur J Clin Invest 40, 294\u2013300. https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02271.x (2010).","journal-title":"Eur J Clin Invest"},{"key":"30712_CR33","first-page":"1122","volume":"7","author":"J Chen","year":"2014","unstructured":"Chen, J., Lu, Y., Huang, D., Luo, X. & Zhang, Y. Relationship of osteopontin and renal function with severity of coronary artery lesions. Int J Clin Exp Med 7, 1122\u20131127 (2014).","journal-title":"Int J Clin Exp Med"},{"key":"30712_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000546236","volume":"15","author":"MA Ohlsson","year":"2025","unstructured":"Ohlsson, M. A. et al. Biomarkers associated with worsening renal function and progression in chronic kidney disease among patients hospitalized for acute heart failure. Cardiorenal Med 15, 453\u2013461. https:\/\/doi.org\/10.1159\/000546236 (2025).","journal-title":"Cardiorenal Med"},{"key":"30712_CR35","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/ndt\/gfac173","volume":"38","author":"I Steinbrenner","year":"2023","unstructured":"Steinbrenner, I. et al. Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: The GCKD study. Nephrol Dial Transplant 38, 1430\u20131438. https:\/\/doi.org\/10.1093\/ndt\/gfac173 (2023).","journal-title":"Nephrol Dial Transplant"},{"key":"30712_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-981-13-6657-4_11","volume":"1132","author":"DP Wallace","year":"2019","unstructured":"Wallace, D. P. Periostin in the kidney. Adv Exp Med Biol 1132, 99\u2013112. https:\/\/doi.org\/10.1007\/978-981-13-6657-4_11 (2019).","journal-title":"Adv Exp Med Biol"},{"key":"30712_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213388","author":"J Muratsu","year":"2022","unstructured":"Muratsu, J. et al. Blocking periostin prevented development of inflammation in rhabdomyolysis-induced acute kidney injury mice model. Cells https:\/\/doi.org\/10.3390\/cells11213388 (2022).","journal-title":"Cells"},{"key":"30712_CR38","doi-asserted-by":"publisher","first-page":"F1695","DOI":"10.1152\/ajprenal.00246.2018","volume":"315","author":"A Raman","year":"2018","unstructured":"Raman, A. et al. Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease. Am J Physiol Renal Physiol 315, F1695\u2013F1707. https:\/\/doi.org\/10.1152\/ajprenal.00246.2018 (2018).","journal-title":"Am J Physiol Renal Physiol"},{"key":"30712_CR39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/ki.2013.488","volume":"85","author":"DP Wallace","year":"2014","unstructured":"Wallace, D. P. et al. Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease. Kidney Int 85, 845\u2013854. https:\/\/doi.org\/10.1038\/ki.2013.488 (2014).","journal-title":"Kidney Int"},{"key":"30712_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ki.2012.186","volume":"82","author":"J Lu","year":"2012","unstructured":"Lu, J. et al. Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation. Kidney Int 82, 436\u2013444. https:\/\/doi.org\/10.1038\/ki.2012.186 (2012).","journal-title":"Kidney Int"},{"key":"30712_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 21, 37\u201346. https:\/\/doi.org\/10.1038\/nm.3762 (2015).","journal-title":"Nat Med"},{"key":"30712_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan, Q., Tang, B. & Zhang, C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 7, 182. https:\/\/doi.org\/10.1038\/s41392-022-01036-5 (2022).","journal-title":"Signal Transduct Target Ther"},{"key":"30712_CR43","doi-asserted-by":"publisher","first-page":"22649","DOI":"10.18632\/aging.203580","volume":"13","author":"JN An","year":"2021","unstructured":"An, J. N. et al. Effects of periostin deficiency on kidney aging and lipid metabolism. Aging 13, 22649\u201322665. https:\/\/doi.org\/10.18632\/aging.203580 (2021).","journal-title":"Aging"},{"key":"30712_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94818","author":"W Ding","year":"2018","unstructured":"Ding, W. et al. Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.94818 (2018).","journal-title":"JCI Insight"},{"key":"30712_CR45","doi-asserted-by":"publisher","first-page":"28882","DOI":"10.1038\/srep28882","volume":"6","author":"Z Pei","year":"2016","unstructured":"Pei, Z. et al. Osteopontin deficiency reduces kidney damage from hypercholesterolemia in apolipoprotein E-deficient mice. Sci Rep 6, 28882. https:\/\/doi.org\/10.1038\/srep28882 (2016).","journal-title":"Sci Rep"},{"key":"30712_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000488816","volume":"46","author":"MC Bulbul","year":"2018","unstructured":"Bulbul, M. C. et al. Disorders of lipid metabolism in chronic kidney disease. Blood Purif 46, 144\u2013152. https:\/\/doi.org\/10.1159\/000488816 (2018).","journal-title":"Blood Purif"},{"key":"30712_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.118615","volume":"398","author":"E Giardini","year":"2024","unstructured":"Giardini, E., Moore, D., Sadlier, D., Godson, C. & Brennan, E. The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies. Atherosclerosis 398, 118615. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118615 (2024).","journal-title":"Atherosclerosis"},{"key":"30712_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","volume":"106","author":"LE Lee","year":"2024","unstructured":"Lee, L. E., Doke, T., Mukhi, D. & Susztak, K. The key role of altered tubule cell lipid metabolism in kidney disease development. Kidney Int 106, 24\u201334. https:\/\/doi.org\/10.1016\/j.kint.2024.02.025 (2024).","journal-title":"Kidney Int"},{"key":"30712_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117050","volume":"177","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. The mechanisms underlying acute myocardial infarction in chronic kidney disease patients undergoing hemodialysis. Biomed Pharmacother 177, 117050. https:\/\/doi.org\/10.1016\/j.biopha.2024.117050 (2024).","journal-title":"Biomed Pharmacother"},{"key":"30712_CR50","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","volume":"91\u201392","author":"M AlQudah","year":"2020","unstructured":"AlQudah, M., Hale, T. M. & Czubryt, M. P. Targeting the renin-angiotensin-aldosterone system in fibrosis. Matrix Biol 91\u201392, 92\u2013108. https:\/\/doi.org\/10.1016\/j.matbio.2020.04.005 (2020).","journal-title":"Matrix Biol"},{"key":"30712_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fphar.2017.00313","volume":"8","author":"GH Tesch","year":"2017","unstructured":"Tesch, G. H. & Young, M. J. Mineralocorticoid receptor signaling as a therapeutic target for renal and cardiac fibrosis. Front Pharmacol 8, 313. https:\/\/doi.org\/10.3389\/fphar.2017.00313 (2017).","journal-title":"Front Pharmacol"},{"key":"30712_CR52","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cjca.2018.12.027","volume":"35","author":"J Benes","year":"2019","unstructured":"Benes, J. et al. The role of GDF-15 in heart failure patients with chronic kidney disease. Can J Cardiol 35, 462\u2013470. https:\/\/doi.org\/10.1016\/j.cjca.2018.12.027 (2019).","journal-title":"Can J Cardiol"},{"key":"30712_CR53","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021661","volume":"10","author":"T Sen","year":"2021","unstructured":"Sen, T. et al. Association between circulating GDF-15 and cardio-renal outcomes and effect of canagliflozin: Results from the CANVAS trial. J Am Heart Assoc 10, e021661. https:\/\/doi.org\/10.1161\/JAHA.121.021661 (2021).","journal-title":"J Am Heart Assoc"},{"key":"30712_CR54","doi-asserted-by":"publisher","first-page":"21681","DOI":"10.1038\/srep21681","volume":"6","author":"T Ishige","year":"2016","unstructured":"Ishige, T. et al. Combined secretomics and transcriptomics revealed cancer-derived GDF15 is involved in diffuse-type gastric cancer progression and fibroblast activation. Sci Rep 6, 21681. https:\/\/doi.org\/10.1038\/srep21681 (2016).","journal-title":"Sci Rep"},{"key":"30712_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112010","volume":"391","author":"Y Takenouchi","year":"2020","unstructured":"Takenouchi, Y., Kitakaze, K., Tsuboi, K. & Okamoto, Y. Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts. Exp Cell Res 391, 112010. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112010 (2020).","journal-title":"Exp Cell Res"},{"key":"30712_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1667\/RADE-20-00206.1","volume":"196","author":"H Guo","year":"2021","unstructured":"Guo, H. et al. GDF15 promotes cardiac fibrosis and proliferation of cardiac fibroblasts via the MAPK\/ERK1\/2 pathway after irradiation in rats. Radiat Res 196, 183\u2013191. https:\/\/doi.org\/10.1667\/RADE-20-00206.1 (2021).","journal-title":"Radiat Res"},{"key":"30712_CR57","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024668","volume":"11","author":"GA Lewis","year":"2022","unstructured":"Lewis, G. A. et al. Characteristics associated with growth differentiation factor 15 in heart failure with preserved ejection fraction and the impact of pirfenidone. J Am Heart Assoc 11, e024668. https:\/\/doi.org\/10.1161\/JAHA.121.024668 (2022).","journal-title":"J Am Heart Assoc"},{"key":"30712_CR58","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/eurjhf\/hfs120","volume":"14","author":"SI Lok","year":"2012","unstructured":"Lok, S. I. et al. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support. Eur J Heart Fail 14, 1249\u20131256. https:\/\/doi.org\/10.1093\/eurjhf\/hfs120 (2012).","journal-title":"Eur J Heart Fail"},{"key":"30712_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.11909\/j.issn.1671-5411.2016.01.002","volume":"13","author":"FF Wang","year":"2016","unstructured":"Wang, F. F. et al. Correlation between growth differentiation factor-15 and collagen metabolism indicators in patients with myocardial infarction and heart failure. J Geriatr Cardiol 13, 88\u201393. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2016.01.002 (2016).","journal-title":"J Geriatr Cardiol"},{"key":"30712_CR60","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038675","volume":"14","author":"BE Mumma","year":"2025","unstructured":"Mumma, B. E. et al. Growth differentiation factor-15 is associated with acute myocardial infarction and death at 30 and 90 days in emergency department patients with suspected acute coronary syndrome. J Am Heart Assoc 14, e038675. https:\/\/doi.org\/10.1161\/JAHA.124.038675 (2025).","journal-title":"J Am Heart Assoc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30712-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30712-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30712-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T23:01:31Z","timestamp":1765580491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30712-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["30712"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30712-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"43267"}}